Lime Therapeutics is the lipids company.
We reversing lysosomal lipid dysfunction due to aging, environment, and genetic mutations in cancer and cardiometabolic disorders. We have developed a first-of-its-kind real-time lipid-detection platform, LipidSense™, to identify new targets and screen for novel drug candidates.
In addition to our internal cancer drug discovery efforts, we have a partnership with Novo Nordisk in the field of atherosclerosis. In the future, Lime will expand its therapeutic development efforts in neurodegeneration, liver disease, and lysosomal storage disorders.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 180 Varick St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.limetherapeutics.com
- HQ
- New York, NY
Lime Therapeutics Questions
Lime Therapeutics's website is http://www.limetherapeutics.com
Lime Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lime-therapeutics
Lime Therapeutics has
5 employees.
View email and phone details for 5
employees at Lime Therapeutics.
Lime Therapeutics's industry is
Biotechnology Research
Lime Therapeutics's top competitors are
Waypoint Bio,
Termeer Institute,
Neptune Bio,
Bluerock Therapeutics,
Ochre Bio,
Tezcat Biosciences,
Synthis Therapeutics, Inc.,
Kallyope,
Biolabs@nyulangone,
Nilo Therapeutics.
Lime Therapeutics's categories are Biotechnology Research
Lime Therapeutics's founding year is 2021
